Answers are grounded in this paper and cite their sources.
Administration of intravenous recombinant tissue plasminogen activation ( rtPA ) administered within 3 hours of symptom onset is an effective therapy for acute ischemic stroke (1,2). The efficacy of thrombolysis has been demonstrated despite an increased risk of severe hemorrhagic transformation (HT) in patient treated with rtPA. (3) We report a case of acute ischemic stroke in a woman who during thrombolysis treatment with rtPA suffered an intracerebral haemorrhage and a new ischemic stroke on the opposite side.
No takes yet. Share an insight, caveat, or question.
A 2006 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: